Cannabis boom or bust: How US firms could be affected by Canada’s adult-use market

It’s crunch time for Canada’s hashish corporations as they hustle to organize for the October launch of the nation’s authorized leisure market.

South of the border, everybody tied to the authorized marijuana scene is watching intently to gauge whether or not this historic milestone may translate into an financial boom for U.S. firms as nicely.

Tremendous alternatives for U.S. and Canadian hashish corporations exist as capital markets open and the sector continues to turn into legitimized, noticed Ben Kovler, founder and chairman of Chicago-based Green Thumb Industries, a multistate medical marijuana grower and dispensary operator.

“The shift in institutional investor sentiment within the space is apparent, and investors are waking up to the opportunities in the cannabis sector,” he stated.

But not everyone seems to be as optimistic – or sure.

Derek Peterson

“The worry is that you’re seeing companies in Canada get a head start on us,” stated Derek Peterson, CEO of Irvine, California-based TerraTech, an operator of hashish cultivation and retail amenities within the Golden State and Nevada.

“That means I’m either building my company to be a great standalone firm … in anticipation that federal policy in the U.S. will change … or I want to position my firm to be the most attractive takeout target it can be as (Canadian) companies look to the U.S. to deploy capital.”

Marijuana Business Daily spoke with hashish executives and insiders to get their perception on the influence Canada’s adult-use market could have on companies within the United States.

Here are their prime takeaways and forecasts:

 U.S. hashish firms falling behind – for now

Jeanne Sullivan

Jeanne Sullivan, associate at San Francisco-based Arcview Investment Group: “The (move to adult use in Canada) officially makes the U.S. laggards in the cannabis sector compared to Canada and other countries. The U.S. has the capability, the knowledge and the ability to lead the world in the research, in production and sales of cannabis products and services. Instead, the stigma remains despite overwhelming support for cannabis products by the U.S. population.”

George Allen

George Allen, president of New York-based Acreage Holdings: “Massive capital investment (in Canada) has been made into cultivation and supply. It will be interesting to see if these paper tigers can live up to their investor promises. The U.S. market has evolved in a reverse manner. Legalization of cannabis has, to a large extent, preceded investor participation. U.S. investors have been sidelined by this immensely attractive market due to anxiety over the federal government’s posture while U.S. states have gradually accepted cannabis and piecemealed legalization. While the Canadian market is a promising indicator of what the U.S. market will look like, we are far more optimistic about the prospects for investment returns in the U.S.”

M&A, spinoffs and licensing offers more likely to decide up

William Simpson

William Simpson, CEO of Toronto-based Golden Leaf: “As you see an increase in revenue and cash flow with Canadian companies, that will accelerate the pace at which they acquire U.S. firms and invest in the U.S. Some of this is already happening, and recently we’ve seen some big announcements from firms like Aurora (Cannabis) – which just spun off a U.S. company. I think more of that activity is on the way.”

Frank Lane

Frank Lane, president of Seattle-based CFN Media: “The biggest opportunities for U.S.-based firms will be in licensing. The U.S. has a much more developed cannabis extracts and edibles market, so there will be many opportunities for licensing joint ventures with Canadian licensed producers to launch these types of products north of the border over time.”

Without coverage change, U.S. entry to capital stays restricted

Alan Litwack

Alan Litwack, lawyer at Toronto-based Dickinson Wright: “Compared to Canadian companies, U.S. companies are being hindered from becoming major operators in terms of ability to scale, access to capital, ability to create brands, R&D and technology. U.S. cannabis operators aren’t able to be listed on the major American exchanges, which limits the ability of U.S. businesses to finance acquisitions of other U.S. cannabis operations and allows for larger players in Canada who can scale both across Canada and internationally. With a few exceptions, including players with strong brands in the U.S., the U.S. cannabis industry operators are going to remain bit players in what is becoming a major worldwide industry.”

Bob Fireman

Bob Fireman, CEO of Massachusetts-based MariMed: “The legalization of cannabis in Canada will continue to allow the Canadian stock exchanges and investment banks to lead the world in the development of equity and wealth. With this capital, Canadian companies are already acquiring U.S. cannabis businesses and assets for their portfolios … U.S. institutional investors, hedge funds and others are refraining from such investments in fear of federal prosecution.”

Lisa Bernard-Kuhn can be reached at [email protected]


Be the first to comment

Leave a Reply

Your email address will not be published.